Why the study?
Does chronic chemical sympathetic denervation protect the rabbit heart against ischemia?
Does chronic chemical sympathetic denervation protect the rabbit heart against ischemia?
Chronic chemical sympathectomy with 6-hydroxydopamine does not protect the rabbit heart against ischemia-reperfusion injury or induce collateral growth.
Chronic sympathectomy does not limit infarct size in rabbits; leaves open translation of denervation-mediated protection to other species or humans.
We determined whether chronic chemical sympathetic denervation could protect the rabbit heart against ischemia. Rabbits received 10 mg/kg 6-hydroxydopamine (6-HD) twice during the first week, then 100 mg.kg-1.wk-1 for the following 7 wk. After this interval the rabbits were anesthetized, the chests were opened, and in each a coronary branch was occluded for 45 min followed by reperfusion for 3 h. Collateral flow was determined with radioactive microspheres during coronary occlusion. Flow to the ischemic myocardium of the 6-HD group (0.06 +/- 0.03 ml.min-1.g-1) was not significantly different from that in the control group (0.04 +/- 0.02 ml.min-1.g-1). Infarct size was determined with triphenyltetrazolium chloride staining. Average infarct size calculated as a percentage of risk zone was similar in the 6-HD and control groups (59 +/- 15 and 60 +/- 12%, respectively). We conclude that chronic chemical sympathectomy does not induce collateral growth in the rabbit heart. Furthermore, endogenous catecholamines do not contribute to injury in the ischemic rabbit heart.
No takes yet. Share an insight, caveat, or question.
Matsuki et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: